338 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Macular Degeneration"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Wet Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
2 Recruiting OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: OZURDEX
3 Unknown  Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
4 Unknown  Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control
5 Unknown  Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: ORA102 and Avastin;   Drug: Avastin
6 Recruiting Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: Ranibizumab 0.5mg
7 Not yet recruiting A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Wet Age-related Macular Degeneration (DRAW).
Condition: Neovascular Macular Degeneration
Intervention: Drug: Aflibercept
8 Unknown  Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
9 Recruiting Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Regorafenib, ophthalmic oily suspension (BAY73-4506);   Procedure: Sham IVT;   Drug: Ranibizumab;   Drug: Placebo
10 Recruiting Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
Condition: Wet Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
11 Unknown  Subretinal Macugen® for Neovascular Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: Pegaptanib (Macugen®)
12 Recruiting X-82 to Treat Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration (AMD);   Macular Degeneration;   Exudative Age-related Macular Degeneration;   AMD;   Macular Degeneration, Age-related, 10;   Eye Diseases;   Retinal Degeneration;   Retinal Diseases
Interventions: Drug: X-82;   Drug: Aflibercept;   Drug: Placebo
13 Recruiting Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration
Conditions: Exudative Macular Degeneration;   Retinal Hemorrhage
Interventions: Drug: Ranibizumab;   Drug: C3F8 Gas;   Drug: tPA
14 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
15 Recruiting Proton Radiation Therapy for Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Radiation: Proton radiation
16 Unknown  Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
Condition: Age-Related Neovascular Macular Degeneration
Interventions: Drug: bevacizumab;   Drug: ranibizumab
17 Unknown  Copaxone in Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Copaxone (Glatiramer acetate)
18 Recruiting LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration
Condition: Exudative Age-Related Macular Degeneration
Interventions: Drug: LHA510 ophthalmic suspension;   Drug: LHA510 vehicle;   Drug: Ranibizumab ophthalmic solution
19 Recruiting Study of Dark Adaptation in Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
20 Recruiting Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: Aflibercept (EYLEA)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years